Insmed Incorporated
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEOWilliam H. Lewis
CEOWilliam H. Lewis
Employees1,271
Employees1,271
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1988
Founded1988
Employees1,271
Employees1,271
INSM Key Statistics
Market cap34.66B
Market cap34.66B
Price-Earnings ratio-28.75
Price-Earnings ratio-28.75
Dividend yield—
Dividend yield—
Average volume2.18M
Average volume2.18M
High today$166.44
High today$166.44
Low today$162.08
Low today$162.08
Open price$163.50
Open price$163.50
Volume1.44M
Volume1.44M
52 Week high$166.44
52 Week high$166.44
52 Week low$60.40
52 Week low$60.40
INSM News
Simply Wall St 2d
Insmed Valuation in Focus After Major Insider Sales and Rising Growth OptimismInsmed (INSM) has drawn attention after several insiders, including the President, sold large amounts of company stock in the past quarter. No insiders made any...
Barchart 6d
This ‘Strong Buy’ Stock Is Trading at New 20-Year HighsInsmed (INSM) is a biopharmaceutical company with strong momentum. Shares are trading at new 20-year highs. INSM has surged 128% over the past year. Analysts...
Nasdaq 7d
INSM Quantitative Stock AnalysisBelow is Validea's guru fundamental report for INSMED INCORPORATED (INSM). Of the 22 guru strategies we follow, INSM rates highest using our P/B Growth Investor...
Analyst ratings
95%
of 20 ratingsBuy
95%
Hold
5%
Sell
0%
People also own
Based on the portfolios of people who own INSM. This list is generated using Robinhood data, and it’s not a recommendation.